Form D · Other Health Care
My Mercury Risk, Inc.
San Francisco, CA · CIK 0001527323
Offering snapshot reported Aug 4, 2011 · SEC filing
- Reported sold
- $300K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Jul 7, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 4, 2011 | Initial | $300,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-163928
We intend to raise $2,000,000; however, if more investors express interest, then with stockholder approval, we may increase the total offering to as much as $4,000,000.
Source: Form D, filed Aug 4, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lisa A. Conte | Director, Promoter |
| David Ewing Duncan | Director, Promoter |
| Lucy Wise Reckseit | Executive, Promoter |
| Gregory B. Stock | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Napo Pharmaceuticals, Inc. 185 Berry Street, Suite 1300
San Francisco, CA, 94107
San Francisco, CA, 94107